These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 6450468)
1. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Collen D Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468 [No Abstract] [Full Text] [Related]
2. Thrombolytic therapy in the eighties. Verstraete M; Collen D Blood; 1986 Jun; 67(6):1529-41. PubMed ID: 2423156 [No Abstract] [Full Text] [Related]
3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
4. [Tissue plasminogen activator: mechanism of action and thrombolytic properties]. Páramo JA; Collen D Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389 [No Abstract] [Full Text] [Related]
5. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D; Lijnen HR Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451 [TBL] [Abstract][Full Text] [Related]
6. Concepts of clot lysis. Francis CW; Marder VJ Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790 [TBL] [Abstract][Full Text] [Related]
7. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis. Marder VJ; Francis CW Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729 [No Abstract] [Full Text] [Related]
8. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase. Toki N; Takasugi S; Ishizu K; Sato H; Sumi H Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043 [TBL] [Abstract][Full Text] [Related]
9. [Thrombolytics and their use]. Alessi MC; Juhan-Vague I Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O; Rijken DC; Collen D Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339 [TBL] [Abstract][Full Text] [Related]
11. Methods for studying fibrinolytic pathway components in human plasma. Wohl RC; Sinio L; Robbins KC Thromb Res; 1982 Sep; 27(5):523-35. PubMed ID: 6217585 [TBL] [Abstract][Full Text] [Related]
12. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis]. Matsuda T Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968 [No Abstract] [Full Text] [Related]
13. [Enzymatic fibrinolytic agents]. Jamet M; Granthil C; Levy G Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112 [TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy in acute myocardial infarction. A perspective. Sherry S Drugs; 1987; 33 Suppl 3():1-12. PubMed ID: 2960512 [TBL] [Abstract][Full Text] [Related]
16. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin. Reed GL; Matsueda GR; Haber E Trans Assoc Am Physicians; 1988; 101():250-6. PubMed ID: 2480017 [No Abstract] [Full Text] [Related]
17. [The role of histidine-rich glycoprotein in the regulation mechanism of fibrinolysis in humans]. Lijnen HR Verh K Acad Geneeskd Belg; 1982; 44(5-6):307-29. PubMed ID: 6223461 [No Abstract] [Full Text] [Related]
18. The fibrinolytic system and its relation to inflammatory diseases. Clemmensen I; Andersen RB Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164 [No Abstract] [Full Text] [Related]
19. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2. Perides G; Noring R; Klempner MS Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243 [TBL] [Abstract][Full Text] [Related]
20. Characterization and antithrombotic action of tissue plasminogen activator. Bergqvist D; Nilsson IM; Pandolfi M Experientia; 1984 Jan; 40(1):67-8. PubMed ID: 6229416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]